Company Analysis MedinCell S.A.
1. Summary
Advantages
- Price (6.98 $) is less than fair price (7.48 $)
- Current debt level 64.96% is below 100% and has decreased over 5 years from 121.06%.
- The company's current efficiency (ROE=112.65%) is higher than the sector average (ROE=14.51%)
Disadvantages
- Dividends (0%) are below the sector average (1.7%).
- The stock's return over the last year (0%) is lower than the sector average (16.48%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| MedinCell S.A. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 2.2% | 0.2% |
| 90 days | 0% | 1.5% | 4.3% |
| 1 year | 0% | 16.5% | 19.4% |
MDCLF vs Sector: MedinCell S.A. has significantly underperformed the "Healthcare" sector by -16.48% over the past year.
MDCLF vs Market: MedinCell S.A. has significantly underperformed the market by -19.41% over the past year.
Stable price: MDCLF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: MDCLF with weekly volatility of 0% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (6.98 $) is lower than the fair price (7.48 $).
Price not significantly lower than the fair price: The current price (6.98 $) is slightly lower than the fair price by 7.2%.
5.2. P/E
P/E vs Sector: The company's P/E (-11.01) is lower than that of the sector as a whole (45.46).
P/E vs Market: The company's P/E (-11.01) is lower than that of the market as a whole (45.85).
5.3. P/BV
P/BV vs Sector: The company's P/BV (-12.4) is lower than that of the sector as a whole (5.31).
P/BV vs Market: The company's P/BV (-12.4) is lower than that of the market as a whole (4.38).
5.5. P/S
P/S vs Sector: The company's P/S indicator (7.95) is higher than that of the sector as a whole (4.3).
P/S vs Market: The company's P/S indicator (7.95) is lower than that of the market as a whole (12.4).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-16.75) is lower than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (-16.75) is lower than that of the market as a whole (24.93).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.61% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-0.61%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-61.97%).
6.4. ROE
ROE vs Sector: The company's ROE (112.65%) is higher than that of the sector as a whole (14.51%).
ROE vs Market: The company's ROE (112.65%) is higher than that of the market as a whole (51.21%).
6.6. ROA
ROA vs Sector: The company's ROA (-20.38%) is lower than that of the sector as a whole (7.45%).
ROA vs Market: The company's ROA (-20.38%) is lower than that of the market as a whole (36.06%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.14%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.78%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.7%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
